Best GLP-1 Probiotic 2026: Akkermansia Products, Ranked

From $59 a bottle, falling to $23.83 on multi-month bundles. One delayed-release vegetarian capsule daily. We rate this first because it is the only product in the category that solves the engineering problem rather than just naming the organism. Three probiotics with the substrate they feed on: Akkermansia muciniphila, Bifidobacterium infantis and Clostridium butyricum — a butyrate producer — paired with chicory root inulin (211 mg) and potato resistant starch (100 mg). Probiotics without prebiotic substrate are bacteria arriving somewhere with nothing to eat, and fermentation of that substrate is what produces the short-chain fatty acids that signal GLP-1 release in the first place. A delayed-release capsule. Stomach acid sits around pH 1.5–3.5 and is very effective at killing microorganisms. Akkermansia is a strict anaerobe — oxygen kills it — and heat-sensitive, which is why specialty brands have charged $70–$90 a month for it alone. A capsule designed to survive gastric acid is the difference between delivering bacteria and delivering dead ones. Handling that matches the biology: temperature-controlled shipping, refrigerate after opening, small-batch production explicitly to protect label counts. Third-party tested for identity, potency, microbial contamination and heavy metals, at manufacture and again before release, in a cGMP facility. And it tells you who shouldn't take it — pregnancy, breastfeeding, severe immunosuppression, recent IV antibiotics, active C. difficile, under 18 — plus, in its own words, that this is "a daily supplement, not a Rx GLP-1."

Before comparing brands, it is worth knowing exactly what the evidence says, because almost every product on this shelf cites the same single study. Depommier and colleagues, Nature Medicine, 2019. A randomised, double-blind, placebo-controlled pilot: 40 overweight and obese insulin-resistant volunteers enrolled, 32 completed, taking 10^10 bacteria daily — live or pasteurized — for three months. The pasteurized arm produced the headline results:

• Insulin sensitivity — improved 28.62% (p=0.002)
• Insulinaemia — reduced 34.08% (p=0.006)
• Total cholesterol — reduced 8.68% (p=0.02)
• Markers of liver dysfunction and inflammation — improved
• Body weight — down 2.27 kg versus placebo, p=0.091, NOT statistically significant

Products in this category range from about $15 to $90 a month, and the price tells you almost nothing. These four checks do. Apply them to any Akkermansia or GLP-1 probiotic you are considering.

• 1. Is it dosed in CFU (or AFU), not milligrams? Viable organisms are counted, not weighed. "Akkermansia muciniphila 10 mg" — which is what Bioma's label says — tells you the mass of powder and nothing about how many bacteria are alive.
• 2. Are the strains named? Probiotic evidence is strain-specific, not species-specific. Lactobacillus rhamnosus GG has a large clinical literature; an unrelated L. rhamnosus strain inherits none of it. A "19-strain proprietary blend" with no designations cannot be checked against any study.
• 3. Does the capsule survive your stomach? Look for delayed-release, enteric or acid-resistant delivery. An ordinary capsule releases live bacteria into gastric acid, which is where a large share of the dose dies.
• 4. Is it cold-shipped, and does it say to refrigerate? Akkermansia is oxygen- and heat-sensitive. A brand that ships live anaerobes at ambient temperature with no storage guidance has not thought about viability.

$49–$99 a month by formula, with one-time options from $69–$139. We rate Pendulum below CoreAge Rx overall, but it is important to say clearly where it is better, because on one axis it is. Pendulum discloses what our top pick does not. Named strains. AFU dosing — active fluorescent units, an appropriate viable-cell measure. And a genuinely published randomised placebo-controlled trial, which is more than essentially anyone else in this category has. It is, as we put it in our full review, the most scientifically serious company on this shelf. Where it falls down is commercial and interpretive. A no-refund policy puts all the risk on the buyer, and we found a subscription-cancellation complaint pattern. And its most-quoted result — a 0.6% A1c reduction — was a non-significant secondary outcome, retold in marketing as though it were the trial's finding. So the two brands fail in opposite directions. CoreAge Rx builds the product better and prices it at a third of the cost, but does not publish its counts. Pendulum publishes everything and charges you for the privilege with no way to get your money back. If strain-level verification is what you care about most, buy Pendulum. If delivery, handling, price and refund terms matter more, buy CoreAge Rx. Both are defensible; neither is a weight-loss drug.

A number of other products compete in this category. We have reviewed some in depth and flag the others as things to apply the four checks to. Bioma GLP-1 Booster — 3.6 / 10. The clearest example of what to avoid. Akkermansia listed at 10 mg with no potency, no strain, and no statement of whether the organisms are live or pasteurized, alongside a "proprietary probiotic blend" at 15 billion CFU with no strains named. Its funnel recommends a three-to-six-month plan against a 14-day refund window. Full review. Inno Supps Trim Biome GLP-1 — 4.4 / 10. Also lists Akkermansia at exactly 10 mg, alongside triacetin at exactly 200 mg — the same two doses as Bioma, which is the signature of a shared branded-ingredient kit rather than independent formulation. Full review. Supergut — 6.1 / 10. Not an Akkermansia product, but relevant: its resistant potato starch has a published randomised placebo-controlled trial showing significant increases in Bifidobacterium and Akkermansia and fewer diarrhoea- and constipation-associated bowel movements. That trial did not measure GLP-1 or body weight. Full review. We have now run the four checks against the rest of the field, and published the results in Akkermansia GLP-1 probiotics compared. The short version: Codeage GLP-1 Probiotic+ discloses 500 million AFU of the same three species as our top pick, with chicory inulin, at about 33 cents a serving. California Gold Nutrition discloses roughly 1 billion AFU and states which strains are live and which pasteurized, at about 38 cents. Designs for Health Akkermansia Pro GLP-1 pairs live Akkermansia with the clinically studied BPL1 postbiotic using patented oxygen-free technology, but publishes no count. Several products in this field use pasteurized Akkermansia, which — given the 2019 trial — is a legitimate choice rather than a shortcut, provided they say so.

The mechanism is real and worth understanding, because it also explains the ceiling. Fermentable fiber reaches the colon. Gut bacteria ferment it into short-chain fatty acids — acetate, propionate and butyrate. Those SCFAs signal enteroendocrine L-cells in your gut lining to release GLP-1 and PYY. That pathway is textbook physiology. A probiotic-plus-prebiotic product is intervening at the top of it. Now the limit. The GLP-1 your body makes has a half-life of roughly two minutes — DPP-4 destroys it almost immediately. Semaglutide's half-life is about a week. Increasing your own GLP-1 secretion produces slightly larger, slightly more frequent pulses of a hormone your body clears before you have finished your meal. It is not sustained receptor activation, and it is not the same intervention. Where these products earn their place is digestion. The best-evidenced outcomes in this whole space are the bowel-symptom endpoints — the resistant starch trial measured stool consistency and reduced diarrhoea- and constipation-associated bowel movements, and those improved. Constipation and bloating are among the most common complaints on semaglutide and tirzepatide. So the honest positioning: buy a GLP-1 probiotic to make treatment more comfortable, or to support gut health on its own terms. Do not buy one expecting it to replace the medication.